To access this element change to forms mode OFF
Grant Award View - GA166522
StoPain: A randomised placebo-controlled trial to investigate the...
GA ID:
GA166522
Agency:
Department of Health and Aged Care
Approval Date:
17-Apr-2021
Publish Date:
25-May-2021
Category:
Health and Medical Research
Grant Term:
1-Jun-2021 to 31-May-2026
Value (AUD):
$1,780,269.60
(GST inclusive where applicable)
One-off/Ad hoc:
No
Aggregate Grant Award:
No
PBS Program Name:
DoHAC 20/21 1.1 Health Policy Research and Analysis
Grant Program:
2020_MRFF_RCRDUN_RCRDUN_2021_General
Grant Activity:
StoPain: A randomised placebo-controlled trial to investigate the efficacy of an advanced interactive brain-computer interface neuromodulation treatment for spinal cord injury neuropathic pain
Purpose:
Neuropathic pain (NP) is a debilitating secondary condition for persons with spinal cord injury (SCI) and effective pharmacological and nonpharmacological treatments remain elusive. We will test whether a novel Brain-Computer Interface Neuromodulation (BCI-N) treatment offers sustained pain relief for SCI NP. This trial is expected to provide a major sustainable advance in SCI NP management that has tangible implications in the improvement of quality of life of individuals living with SCI NP.
GO ID:
GO Title:
MRFF Clinical Trials Activity Initiative – 2020 Rare Cancers, Rare Diseases and Unmet Need General Grant Opportunity
Internal Reference ID:
MRF2006020
Selection Process:
Targeted or Restricted Competitive
Confidentiality - Contract:
Yes
Confidentiality Reason(s) - Contract:
Privacy Act 1988
Intellectual property
Intellectual property
Confidentiality - Outputs:
Yes
Confidentiality Reason(s) - Outputs:
Intellectual property
Grant Recipient Details
Recipient Name:
University of New South Wales
Recipient ABN:
57 195 873 179
Grant Recipient Location
Suburb:
Sydney
Town/City:
Sydney
Postcode:
2052
State/Territory:
NSW
Country:
AUSTRALIA
Grant Delivery Location
State/Territory:
NSW
Postcode:
Country:
AUSTRALIA